Similar to NDRG1 and TGFβ1, GSK3β is known to have a dual antitumor and oncogenic role depending on the tumor type, including breast cancer 33, to overcome chemoresistance in breast cancer 34, and it was recently found to be expressed at high levels in TNBC, what correlated with less patient survival 35. Here, GSK3B is linked to neoplasm.